LIPITOR Global Safety Backgrounder Final/Updated Safety Message


A multicenter, double-blind, placebo-controlled, randomized, parallel-group,
   fixed dose study to evaluate the efficacy, safety and tolerability of Zelmac
   (tegaserod) in patients with non-D-IBS


벨케이드주(bortezomib)로 재치료 받은 다발성골수종 환자에 대한 전향적 관찰 연구
울트라셋 세미정/울트라셋 정의 투약 실태 조사
주의력 결핍/과잉행동 장애 환아에게 OROS Methylphenidate(ConcertaTM)
   치료 후의 양육 스트레스 변화


Training Material/Product Monograph - Arava
An Annual Report of Ketek Post-marketing Surveillance (PMS)
   and Special Surveillance
An Annual Report of Taxotere Post-marketing Surveillance (PMS)
   and Special Surveillance
A Comparative Study of the Efficacy of Irbesartan/Hydrochlorothiazide 300/25 mg
   versus Valsartan/Hydrochlorothiazide 160/25 mg Using Home Blood Pressure
   Monitoring in the Treatment of Mild to Moderate Hypertension:
   A Controlled, Randomised, Open-label, Multicentre, Phase IIIb/IV study
   [ClinicalTrials.gov Identifier: NCT00500604]